EDGAR Filing Documents for 0001193125-04-197359

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001193125-04-197359

Filing Date

2004-11-15

Accepted

2004-11-15 16:28:50

Documents

Period of Report

2004-09-30

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-Q FOR CORTEX PHARMACEUTICALS, INC. (09/30/2004)	d10q.htm	10-Q	178417
2	CONSULTING AGREEMENT DATED APRIL 16, 2004	dex1084.htm	EX-10.84	38410
3	EMPLOYMENT LETTER OF AGREEMENT DATED JULY 26, 2004	dex1085.htm	EX-10.85	20032
4	AMENDMENT DATED NOVEMBER 10, 2004 TO EMPLOYMENT AGREEMENT DATED OCTOBER 29, 2002	dex1086.htm	EX-10.86	4816
5	CEO CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A)	dex311.htm	EX-31.1	8932
6	CFO CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A)	dex312.htm	EX-31.2	9129
7	CEO & CFO CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350	dex32.htm	EX-32	5165
8	GRAPHIC	g2078743124-1.jpg	GRAPHIC	4199
	Complete submission text file	0001193125-04-197359.txt		271685

Mailing Address 15241 BARRANCA PARKWAY IRVINE CA 92718

Business Address 15241 BARRANCA PKWY IRVINE CA 92718 7147273157

CORTEX PHARMACEUTICALS INC/DE/ (Filer) CIK: 0000849636 (see all company filings)